IP Library Granted Patent US 7,974,696
Granted Patent B1
US 7,974,696 · App. 11/187,315 · Granted Jul 5, 2011

Closed-loop autonomic neuromodulation for optimal control of neurological and metabolic disease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,974,696
App. No.
11/187,315
Granted
Jul 5, 2011
Kind
B1
Abstract

A neurological control system for modulating activity of any component or structure of some or all of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” This system generates neural modulation signals delivered to a nervous system component through one or more neuromodulators to control neurological state or autonomic state and prevent neurological or metabolic signs and symptoms. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals, with sensors configured to sense a particular characteristic indicative of a neurological, psychiatric, or metabolic condition.

Claims (59)

1. A system for modulation of the sympathetic nervous system in the treatment of disease, comprising:

A. a signal conditioning circuit;

B. a sensor array in communication with said signal conditioning circuit;

C. a signal processor in communication with said signal conditioning circuit, wherein said signal processor performs neural state estimation;

D. a control circuit in communication with said signal processor and which calculates an output which is a function of the neural state;

E. an output stage circuit in communication with said control circuit; and

F. a stimulating electrode array, in communication with said output stage circuit, said stimulating electrode array configured to be in communication with a component of the sympathetic nervous system.

2. A system as recited in claim 1 , wherein neural state comprises autonomic index.

3. A system as recited in claim 1 , wherein neural state is controlled to remain within a normal range.

4. A system as recited in claim 1 , wherein autonomic index is controlled to remain within a normal range.

5. A system as recited in claim 1 , wherein neural state is controlled to remain within a control range.

6. A system as recited in claim 1 , wherein autonomic index is controlled to remain within a control range.

7. A system as recited in claim 1 , wherein neural state is controlled to remain outside of a critical range.

8. A system as recited in claim 1 , wherein autonomic index is controlled to remain outside of a critical range.

9. A system as recited in claim 1 , wherein neural state is controlled to prevent the occurrence of at least one of neurological signs and neurological symptoms.

10. A system as recited in claim 1 , wherein autonomic index is controlled to prevent the occurrence of at least one of neurological signs and neurological symptoms.

11. A system as recited in claim 1 , wherein neural state is controlled to prevent the occurrence of metabolic abnormalities.

12. A system as recited in claim 1 , wherein autonomic index is controlled to prevent the occurrence of metabolic abnormalities.

13. A system for neural modulation in the treatment of obesity, comprising:

A. a sensor array in communication with said signal conditioning circuit;

B. a signal processor in communication with said sensor array, whereby said signal processor calculates at least one state;

C. a control circuit in communication with said signal processor and which calculates an output which is a function of the neural state;

D. an output stage circuit in communication with said control circuit; and

E. a neuromodulator array, in communication with said output stage circuit, said neuromodulator array is configured to be in communication with a component of a sympathetic nervous system.

14. A system as recited in claim 13 , wherein neural state comprises autonomic index.

15. A system as recited in claim 13 , wherein neural state is controlled to remain within a normal range.

16. A system as recited in claim 13 , wherein neural state is controlled to remain within a control range.

17. A system for neural modulation in the treatment of metabolic disease, comprising:

A. a sensor array in communication with said signal conditioning circuit;

B. a signal processor in communication with said sensor array, whereby said signal processor calculates at least one state;

C. a control circuit in communication with said signal processor and which uses a control law to calculate an output which is a function of the neural state;

D. an output stage circuit in communication with said control circuit; and

E. a neuromodulator array, in communication with said output stage circuit, said neuromodulator array is configured to be in communication with a component of a sympathetic nervous system.

18. A system as recited in claim 17 , wherein neural state comprises autonomic index.

19. A system as recited in claim 17 , wherein neural state is controlled to remain within a normal range.

20. A system as recited in claim 17 , wherein neural state is controlled to remain within a control range.

21. A system for modulation of the sympathetic nervous system in the treatment of disease, comprising:

A. a signal conditioning circuit;

B. a sensor array in communication with said signal conditioning circuit, said sensor array is configured to be in communication with a component of the sympathetic nervous system;

C. a signal processor in communication with said signal conditioning circuit, wherein said signal processor performs neural state estimation;

D. a control circuit in communication with said signal processor and which calculates an output which is a function of the neural state;

E. an output stage circuit in communication with said control circuit; and

F. a stimulating electrode array, in communication with said output stage circuit.

22. A system for neural modulation in the treatment of obesity, comprising:

A. a sensor array in communication with said signal conditioning circuit, said sensor array configured to be in communication with a component of a sympathetic nervous system;

B. a signal processor in communication with said sensor array, whereby said signal processor calculates at least one state;

C. a control circuit in communication with said signal processor and which calculates an output which is a function of the neural state;

D. an output stage circuit in communication with said control circuit; and

E. a neuromodulator array, in communication with said output stage circuit.

23. A system for neural modulation in the treatment of metabolic disease, comprising:

A. a sensor array in communication with said signal conditioning circuit, said sensor array configured to be in communication with a component of a sympathetic nervous system;

B. a signal processor in communication with said sensor array, whereby said signal processor calculates at least one state;

C. a control circuit in communication with said signal processor and which uses a control law to calculate an output which is a function of the neural state;

D. an output stage circuit in communication with said control circuit; and

E. a neuromodulator array, in communication with said output stage circuit.

24. The system for neural modulation as in claim 1 , 13 , 17 , 21 , 22 , or 23 , wherein said signal processor generates a signal which is a function of activity of a component of the sympathetic nervous system.

25. The system for neural modulation as in claim 1 , 13 , 17 , 21 , 22 , or 23 , wherein said control circuit generates a signal which modulates the activity of a component of the sympathetic nervous system.

26. The system for neural modulation as in claim 1 , 13 , 17 , 21 , 22 , or 23 , wherein said output stage circuit generates a signal which modulates the activity of a component of the sympathetic nervous system.

27. The system for neural modulation as in claim 1 , 13 , 17 , 21 , 22 , or 23 , wherein said neuromodulator array is configured to deliver a signal which modulates the activity of a component of the sympathetic nervous system.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2024
From: LIVANOVA INC.; LIVANOVA USA INC.
To: DILORENZO BIOMEDICAL, LLC
Reel/Frame 067508/0068 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: NEUROVISTA CORPORATION
To: CYBERONICS, INC.
Reel/Frame 066484/0639 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: DILORENZO, DANIEL JOHN
To: BIONEURONICS CORPORATION
Reel/Frame 066621/0207 →
CHANGE OF NAME Recorded Feb 16, 2024
From: BIONEURONICS CORPORATION
To: NEUROVISTA CORPORATION
Reel/Frame 066624/0280 →
CHANGE OF NAME Recorded Feb 16, 2024
From: CYBERONICS, INC.
To: LIVANOVA USA, INC.
Reel/Frame 066624/0288 →
SECURITY INTEREST Recorded Feb 16, 2024
From: NEUROVISTA CORPORATION
To: CYBERONICS, INC.
Reel/Frame 066484/0594 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2021
From: DILORENZO, DANIEL J
To: DILORENZO BIOMEDICAL, LLC
Reel/Frame 055692/0834 →
CERTIFICATE OF ADMINISTRATIVE DISSOLUTION Recorded Mar 23, 2021
From: DILORENZO BIOMEDICAL, LLC
To: DILORENZO, DANIEL J
Reel/Frame 055694/0903 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2011
From: DILORENZO, DANIEL JOHN
To: DILORENZO BIOMEDICAL, LLC
Reel/Frame 026357/0039 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2006
From: DILORENZO, DANIEL JOHN
To: DILORENZO BIOMEDICAL, LLC
Reel/Frame 017274/0287 →